This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper
gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma …

Abstract Backgrounds/Aims: Vonoprazan (VPZ) is the first clinically available potassium
competitive acid blocker. This class of agents provides faster and more potent acid inhibition …

This review considers the data on Helicobacter pylori (H. pylori), which have been
accumulated over 40 years since its description as an etiological factor in gastrointestinal …

Gastrointestinal microbiota have been implicated in the pathogenesis of various
gastrointestinal disorders in dogs, including acute diarrhea and chronic enteropathy …

The cysteine conjugated chitosan/PMLA multifunctional nanoparticles were synthesized as
targeted Nano-drug delivery system to eradicate Helicobacter pylori. Helicobacter pylori …

The covalently modified ureido-conjugated chitosan/TPP multifunctional nanoparticles have
been developed as targeted nanomedicine delivery system for eradication of Helicobacter …

Idiopathic thrombocytopenic purpura (ITP) is typically a diagnosis of exclusion, assigned by
clinicians after ruling out other identifiable etiologies. Since a report by Gasbarrini et al. in …

Bacteria and cancer cells share a unique symbiotic relationship in the process of cancer
development and treatment. It has been shown that certain bacteria can mediate cancer and …

Helicobacter pylori is a major global pathogen, and its infection represents a key factor in the
etiology of various gastric diseases, including gastritis, peptic ulcers, and gastric carcinoma …